Read Larry Connors' blog – Short Term Trading Strategies
Arrowhead's Annual Pain Therapeutics Summit (http://www.arrowheadpublishers.com/conferences/pain-therapeutics-2009/#_overview) is the US's premier conference covering the field of pain management and therapeutics. Leaders from the pharmaceutical, biotech, device and medical communities attend this conference to learn about the latest advances in the treatment of various types of pain and to network with colleagues from industry, academia, the medical community, government and investors.
This year's presentations will highlight the most important developments in recent years in the field, including new research in sodium channel blockers (TRPV1 and TRPA1), late-stage clinical advances with Merck's CGRP antagonist program, new research in biologic therapies, the genetics of pain, abuse-resistant opioids, analysis of FDA's REMS program and a plethora of other topics.
This year's summit will feature presentations from the nation's foremost pain experts: including, (but not limited to):
Frank Porreca, Ph.D., (Chair) Professor, Department of Pharmacology & Anesthesiology, College of Medicine, University of Arizona Daniel B. Carr, MD, Chief Medical Officer & President, Javelin Pharmaceuticals Lynn R. Webster, MD, FACPM, FASAM, Medical Director and Founder, Lifetree Clinical Research & Pain Clinic, Director-At-Large, American Academy of Pain Medicine Theodore J. Cicero, Ph.D., Professor, Departments of Psychiatry and Anatomy and Neurobiology, Washington University in St. Louis Tony Ho, Senior Director Clinical Neuroscience, Merck Research Laboratories Tarek Samad, Ph.D., Head, Pain Molecular Neurobiology, Neuroscience Discovery, Wyeth Research Jeffrey Tobias, MD, Chief Medical Officer, NeurogesX, Inc. Mila Etropolski, MD, Sr. Director, Clinical Leader, Clinical Research and Development, CNS/Pain TA, Johnson and Johnson John S. Andrews, Ph.D., President, Head of R&D, NeurAxon Joseph W. Stauffer, DO, Principal, Alta Life Sciences LLC, Adjunct Assistant Professor, Johns Hopkins University School of Medicine, Department of Anesthesiology & Critical Care Medicine, Division of Pain Medicine, formerly Chief Medical Officer, Senior Vice President Clinical Research & Medical Affairs, Alpharma Inc. For more information about this conference, please visit www.arrowheadpublishers.com, or call 1-312-244-3703, ext. 4.
###
Read the full story at http://www.prweb.com/releases/pain/conference/prweb2540864.htm.
PRWeb.com
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302
© Copyright 2009 The Connors Group, Inc.
